Latest News about XTXXF
Recent news which mentions XTXXF
Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses
April 25, 2024
From Benzinga
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
From Benzinga
Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2
August 18, 2023
Tickers
XTXXF
From Benzinga
Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What's Behind The Figures?
May 31, 2023
Tickers
XTXXF
From Benzinga
Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit
March 16, 2023
Tickers
XTXXF
From Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
From Benzinga
Adastra Clarifies Health Canada Approval To Handle Cocaine
March 06, 2023
Tickers
XTXXF
From Benzinga
Canadian Weed Company's Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment
March 03, 2023
Tickers
XTXXF
From Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
From Benzinga
Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin
August 31, 2022
Tickers
XTXXF
From Benzinga
Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies
May 20, 2022
From Benzinga
Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services
April 11, 2022
Tickers
XTXXF
From Benzinga
Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD
March 25, 2022
Tickers
XTXXF
From Benzinga